Frontiers in Oncology | Genitourinary Oncology

Original Research

Published on 03 Apr 2023

Real-life data of abiraterone acetate and enzalutamide treatment in post-chemotherapy metastatic castration-resistant prostate cancer in Poland

in Genitourinary Oncology

Dawid Sigorski
Michał Wilk
Angelika Gawlik-Urban
Agata Sałek-Zań
Joanna Kiszka
Mateusz Malik
Katarzyna Czerko
Kamil Kuć
Cezary Szczylik
Tomasz Kubiatowski

Frontiers in Oncology

doi 10.3389/fonc.2023.1108937

4,079 views
3 citations

Original Research

Published on 03 Apr 2023

Identification of a prognostic biomarker predicting biochemical recurrence and construction of a novel nomogram for prostate cancer

in Genitourinary Oncology

Zhaojun Yu
Haichao Chao
Fanghua Xu
Huanhuan Deng
Leihong Deng
Zhen Song
Tao Zeng

Frontiers in Oncology

doi 10.3389/fonc.2023.1115718

3,669 views
11 citations

Original Research

Published on 30 Mar 2023

Exploring a ferroptosis and oxidative stress-based prognostic model for clear cell renal cell carcinoma

in Genitourinary Oncology

Dongxu Lin
Bintao Hu
Shiqing Zhu
Yue Wu

Frontiers in Oncology

doi 10.3389/fonc.2023.1131473

5,188 views
14 citations

Case Report

Published on 30 Mar 2023

Malignant glomus tumor of prostate: A case report

in Genitourinary Oncology

Zhanxin Sun
Fuzhen Sun
Chunhong Yu
Helong Xiao
Qingle Xu
Bo Gao
Liuxiong Guo
Junjiang Liu
Shoubin Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1121307

1,921 views
4 citations

Case Report

Published on 30 Mar 2023

Primary squamous cell carcinoma of renal parenchyma: A case report and literature review

in Genitourinary Oncology

Ke Liang
Yichu Yuan
Bodong Lv
Zunjin Ke

Frontiers in Oncology

doi 10.3389/fonc.2023.1037156

6,855 views
8 citations

Original Research

Published on 29 Mar 2023

Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 (“Oligometastatic”) and M2 (“Polymetastatic”) subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC)

in Genitourinary Oncology

Margaret F. Meagher
Maria C. Mir
Andrea Minervini
Maximilian Kriegmair
Matthias Heck
Francesco Porpiglia
Siska Van Bruwaene
Estefania Linares
Vital Hevia
Maurizio D’Anna

Frontiers in Oncology

doi 10.3389/fonc.2023.1113246

2,508 views
5 citations

Review

Published on 29 Mar 2023

Identifying novel biomarkers associated with bladder cancer treatment outcomes

in Genitourinary Oncology

Peris R. Castaneda
Dan Theodorescu
Charles J. Rosser
Michael Ahdoot

Frontiers in Oncology

doi 10.3389/fonc.2023.1114203

6,648 views
26 citations

Original Research

Published on 29 Mar 2023

Identification of a novel defined inflammation-related long noncoding RNA signature contributes to predicting prognosis and distinction between the cold and hot tumors in bladder cancer

in Genitourinary Oncology

Xi Xiong
Chen Chen
Xinxin Li
Jun Yang
Wei Zhang
Xiong Wang
Hong Zhang
Min Peng
Lili Li
Pengcheng Luo

Frontiers in Oncology

doi 10.3389/fonc.2023.972558

4,290 views
14 citations

Original Research

Published on 27 Mar 2023

Risk of malignancy in adrenal tumors in patients with a history of cancer

in Genitourinary Oncology

Radosław Samsel
Karolina Nowak
Lucyna Papierska
Edyta Karpeta
Katarzyna Roszkowska-Purska
Wacław Smiertka
Tomasz Ostrowski
Eryk Chrapowicki
Alan Grabowski
Dorota Leszczyńska

Frontiers in Oncology

doi 10.3389/fonc.2023.1018475

6,374 views
13 citations

Original Research

Published on 27 Mar 2023

Safety and efficacy of iodine-125 seed strand for intraluminal brachytherapy on ureteral carcinoma

in Genitourinary Oncology

Yonghua Bi
Dechao Jiao
Jianhao Zhang
Jianzhuang Ren
Xinwei Han
Kefeng Guo
Xueliang Tu

Frontiers in Oncology

doi 10.3389/fonc.2023.1081258

1,553 views

Original Research

Published on 24 Mar 2023

Integrative analysis of transcriptomic landscape and urinary signature reveals prognostic biomarkers for clear cell renal cell carcinoma

in Genitourinary Oncology

Wei Zhang
Wenqiang Liu
Yiren Yang
Chengwu Xiao
Yutian Xiao
Xiaojie Tan
Qingyang Pang
Han Wu
Meimian Hua
Xiaolei Shi

Frontiers in Oncology

doi 10.3389/fonc.2023.1102623

3,147 views
3 citations

Original Research

Published on 24 Mar 2023

Integrated bioinformatic analysis and cell line experiments reveal the significant role of the novel immune checkpoint TIGIT in kidney renal clear cell carcinoma

in Genitourinary Oncology

Qi-Dong Xia
Bo Li
Jian-Xuan Sun
Chen-Qian Liu
Jin-Zhou Xu
Ye An
Meng-Yao Xu
Si-Han Zhang
Xing-Yu Zhong
Na Zeng

Frontiers in Oncology

doi 10.3389/fonc.2023.1096341

3,950 views
7 citations

Correction

Published on 23 Mar 2023

Corrigendum: The learning curve for robot-assisted radical cystectomy with total intracorporeal urinary diversion based on radical cystectomy pentafecta

in Genitourinary Oncology

Tae Il Noh
Ji Sung Shim
Sung Gu Kang
Jun Cheon
Jong Hyun Pyun
Seok Ho Kang

Frontiers in Oncology

doi 10.3389/fonc.2023.1185908

1,233 views

Original Research

Published on 23 Mar 2023

Diagnostic performance of transperineal prostate targeted biopsy alone according to the PI-RADS score based on bi-parametric magnetic resonance imaging

in Genitourinary Oncology

Tae Il Noh
Ji Sung Shim
Seok Ho Kang
Jun Cheon
Sung Gu Kang

Frontiers in Oncology

doi 10.3389/fonc.2023.1142022

2,290 views
1 citation

Case Report

Published on 22 Mar 2023

Cardiac infarction caused by PD-1 inhibitor during small cell neuroendocrine carcinoma of the ureter treatment: A case report

in Genitourinary Oncology

Xiaoying Li
Jing Wen
Hongtao Li
Yan Huang
Hongliang Zhou

Frontiers in Oncology

doi 10.3389/fonc.2023.1114397

1,328 views

Original Research

Published on 22 Mar 2023

Identification of an immune subtype-related prognostic signature of clear cell renal cell carcinoma based on single-cell sequencing analysis

in Genitourinary Oncology

Zongyao Fan
Hewei Xu
Qingyu Ge
Weilong Li
Junjie Zhang
Yannan Pu
Zhengsen Chen
Sicong Zhang
Jun Xue
Baixin Shen

Frontiers in Oncology

doi 10.3389/fonc.2023.1067987

2,750 views
1 citation

Original Research

Published on 22 Mar 2023

Correlation between the timing of diagnostic ureteroscopy for upper tract urothelial cancer and intravesical recurrence after radical nephroureterectomy

in Genitourinary Oncology

Zhenkai Luo
Binbin Jiao
Caixia Su
Hang Zhao
Yangxuanyu Yan
Yijin Pan
Jian Ren
Guan Zhang
Zhenshan Ding

Frontiers in Oncology

doi 10.3389/fonc.2023.1122877

2,230 views
3 citations

Review

Published on 21 Mar 2023

Histone methyltransferase SETD2: An epigenetic driver in clear cell renal cell carcinoma

in Genitourinary Oncology

Mengxue Yu
Kaiyu Qian
Gang Wang
Yu Xiao
Yuan Zhu
Lingao Ju

Frontiers in Oncology

doi 10.3389/fonc.2023.1114461

7,905 views
14 citations

Review

Published on 21 Mar 2023

Importance of long non-coding RNAs in the pathogenesis, diagnosis, and treatment of prostate cancer

in Genitourinary Oncology

Mohammad Taheri
Elham Badrlou
Bashdar Mahmud Hussen
Amir Hossein Kashi
Soudeh Ghafouri-Fard
Aria Baniahmad

Frontiers in Oncology

doi 10.3389/fonc.2023.1123101

6,267 views
22 citations

Original Research

Published on 21 Mar 2023

Effects of walking football on adherence, safety, quality of life and physical fitness in patients with prostate cancer: Findings from the PROSTATA_MOVE randomized controlled trial

in Genitourinary Oncology

Andreia Capela
Pedro Antunes
César André Coelho
Catarina Laranjeiro Garcia
Sandra Custódio
Rui Amorim
Telma Costa
Eduardo Vilela
Madalena Teixeira
Anabela Amarelo

Frontiers in Oncology

doi 10.3389/fonc.2023.1129028

7,036 views
14 citations

Original Research

Published on 21 Mar 2023

Choline PET/CT in recurrent prostate cancer

in Genitourinary Oncology

Beatrice Detti
Maria Grazia Carnevale
Sara Lucidi
Luca Burchini
Saverio Caini
Carolina Orsatti
Niccolò Bertini
Manuele Roghi
Vanessa di Cataldo
Simona Fondelli

Frontiers in Oncology

doi 10.3389/fonc.2023.1079808

2,720 views
5 citations

Original Research

Published on 21 Mar 2023

Cognitive impairment and biomarkers of gut microbial translocation in testicular germ cell tumor survivors

in Genitourinary Oncology

Michal Chovanec
Katarina Kalavska
Jana Obertova
Patrik Palacka
Katarina Rejlekova
Zuzana Sycova-Mila
Zuzana Orszaghova
Peter Lesko
Valentina De Angelis
Lucia Vasilkova

Frontiers in Oncology

doi 10.3389/fonc.2023.1146032

3,109 views
4 citations

Original Research

Published on 21 Mar 2023

Identification of endothelial-related molecular subtypes for bladder cancer patients

in Genitourinary Oncology

Deng-xiong Li
De-chao Feng
Xu Shi
Rui-cheng Wu
Kai Chen
Ping Han

Frontiers in Oncology

doi 10.3389/fonc.2023.1101055

5,280 views
28 citations

Review

Published on 21 Mar 2023

Osteoid cell-derived chemokines drive bone-metastatic prostate cancer

in Genitourinary Oncology

Catherine S. Johnson
Leah M. Cook

Frontiers in Oncology

doi 10.3389/fonc.2023.1100585

4,812 views
5 citations

1,822 articles

articles

Real-life data of abiraterone acetate and enzalutamide treatment in post-chemotherapy metastatic castration-resistant prostate cancer in Poland

Identification of a prognostic biomarker predicting biochemical recurrence and construction of a novel nomogram for prostate cancer

Exploring a ferroptosis and oxidative stress-based prognostic model for clear cell renal cell carcinoma

Malignant glomus tumor of prostate: A case report

Primary squamous cell carcinoma of renal parenchyma: A case report and literature review

Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 (“Oligometastatic”) and M2 (“Polymetastatic”) subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC)

Identifying novel biomarkers associated with bladder cancer treatment outcomes

Identification of a novel defined inflammation-related long noncoding RNA signature contributes to predicting prognosis and distinction between the cold and hot tumors in bladder cancer

Risk of malignancy in adrenal tumors in patients with a history of cancer

Safety and efficacy of iodine-125 seed strand for intraluminal brachytherapy on ureteral carcinoma

Integrative analysis of transcriptomic landscape and urinary signature reveals prognostic biomarkers for clear cell renal cell carcinoma

Integrated bioinformatic analysis and cell line experiments reveal the significant role of the novel immune checkpoint TIGIT in kidney renal clear cell carcinoma

Corrigendum: The learning curve for robot-assisted radical cystectomy with total intracorporeal urinary diversion based on radical cystectomy pentafecta

Diagnostic performance of transperineal prostate targeted biopsy alone according to the PI-RADS score based on bi-parametric magnetic resonance imaging

Cardiac infarction caused by PD-1 inhibitor during small cell neuroendocrine carcinoma of the ureter treatment: A case report

Identification of an immune subtype-related prognostic signature of clear cell renal cell carcinoma based on single-cell sequencing analysis

Correlation between the timing of diagnostic ureteroscopy for upper tract urothelial cancer and intravesical recurrence after radical nephroureterectomy

Histone methyltransferase SETD2: An epigenetic driver in clear cell renal cell carcinoma

Importance of long non-coding RNAs in the pathogenesis, diagnosis, and treatment of prostate cancer

Effects of walking football on adherence, safety, quality of life and physical fitness in patients with prostate cancer: Findings from the PROSTATA_MOVE randomized controlled trial

Choline PET/CT in recurrent prostate cancer

Cognitive impairment and biomarkers of gut microbial translocation in testicular germ cell tumor survivors

Identification of endothelial-related molecular subtypes for bladder cancer patients

Osteoid cell-derived chemokines drive bone-metastatic prostate cancer